Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00464893
Recruitment Status : Completed
First Posted : April 24, 2007
Last Update Posted : December 4, 2013
Sponsor:
Information provided by (Responsible Party):
Neovii Biotech